Epidemiologic studies of psychosocial factors associated with quality of life among patients with chronic diseases in Japan

Journal of Epidemiology

Volumn 22, Issue 1, 2012, Pages 7-11

  Kojima, Masayo ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Alexithymia; Depression; Hemodialysis; Rheumatoid arthritis; Risk factors

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CROSS-SECTIONAL STUDY; DEPRESSION; EMOTIONAL DISORDER; EPIDEMIOLOGY; FOLLOW UP; HUMAN; JAPAN; MIDDLE AGED; MORTALITY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RENAL REPLACEMENT THERAPY; RHEUMATOID ARTHRITIS; RISK FACTOR; SOCIAL SUPPORT;

ADULT; AFFECTIVE SYMPTOMS; AGED; ARTHRITIS, RHEUMATOID; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; DEPRESSION; EPIDEMIOLOGIC STUDIES; FOLLOW-UP STUDIES; HUMANS; JAPAN; MIDDLE AGED; QUALITY OF LIFE; RENAL DIALYSIS; RISK FACTORS; SOCIAL SUPPORT; YOUNG ADULT;

EID: 84855560174     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.JE20110114     Document Type: Article

References (29)

1. Grad FP. The Preamble of the Constitution of the World Health Organization. Bull World Health Organ. 2002;80(12): 981-4.
2. Williams RB. The role of the brain in physical disease. Folklore, normal science, or paradigm shift? JAMA. 1990;263(14): 1971-2.
3. Engel GL. The need for a new medical model: a challenge for biomedicine. Science. 1977;196(4286):129-36.
4. Fassino S. Psychosomatic approach is the new medicine tailored for patient personality with a focus on ethics, economy, and quality. Panminerva Med. 2010;52(3):249-64.
5. WHO. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva: World Health organization; 2009.
6. Prince M, Patel V, Saxena S, Maj M, Maselko J, Phillips MR, et al. No health without mental health. Lancet. 2007;370(9590): 859-77.
7. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006; 3(11):e442.
8. Cohen S, Rodriquez MS. Pathways linking affective disturbances and physical disorders. Health Psychol. 1995;14(5): 374-80.
9. Kojima M, Kojima T, Suzuki S, Oguchi T, Oba M, Tsuchiya H, et al. Depression, inflammation, and pain in patients with rheumatoid arthritis. Arthritis Rheum. 2009;61(8):1018-24.
10. Kojima M, Kojima T, Ishiguro N, Oguchi T, Oba M, Tsuchiya H, et al. Psychosocial factors, disease status, and quality of life in patients with rheumatoid arthritis. J Psychosom Res. 2009; 67(5):425-31.
11. Kojima M, Hayano J, Tokudome S, Suzuki S, Ibuki K, Tomizawa H, et al. Independent associations of alexithymia and social support with depression in hemodialysis patients. J Psychosom Res. 2007;63(4):349-56.
12. Kojima M, Hayano J, Suzuki S, Seno H, Kasuga H, Takahashi H, et al. Depression, alexithymia and long-term mortality in chronic hemodialysis patients. Psychother Psychosom. 2010; 79(5):303-11.
13. Kojima M, Hayano J, Fukuta H, Sakata S, Mukai S, Ohte N, et al. Loss of fractal heart rate dynamics in depressive hemodialysis patients. Psychosom Med. 2008;70(2):177-85.
14. Ang DC, Choi H, Kroenke K, Wolfe F. Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis. J Rheumatol. 2005;32(6):1013-9.
15. Beck AT, Steer RA. Manual for the Beck Depression Inventory- 2. San Antonio, TX: Psychological Corporation; 1996.
16. Kojima M, Furukawa TA, Takahashi H, Kawai M, Nagaya T, Tokudome S. Cross-cultural validation of the Beck Depression Inventory-II in Japan. Psychiatry Res. 2002;110(3):291-9.
17. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-70.
18. Furukawa TA, Harai H, Hirai T, Kitamura T, Takahashi K. Social Support Questionnaire among psychiatric patients with various diagnoses and normal controls. Soc Psychiatry Psychiatr Epidemiol. 1999;34(4):216-22.
19. Sarason BR, Levine HM, Basham RB, Sarason IG. Assessing social support: the Social Support Questionnaire. J Pers Soc Psychol. 1983;44:127-39.
20. Fukuhara S, Suzukamo Y. Manual of SF36v2 Japanese version. Kyoto: Institute for Health Outcomes & Process Evaluation Research; 2004.
21. Fukuhara S, Ware JE Jr, Kosinski M, Wada S, Gandek B. Psychometric and clinical tests of validity of the Japanese SF-36 Health Survey. J Clin Epidemiol. 1998;51(11):1045-53.
22. Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K. Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J Clin Epidemiol. 1998;51(11):1037-44.
23. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473-83.
24. Hedayati SS, Bosworth HB, Briley LP, Sloane RJ, Pieper CF, Kimmel PL, et al. Death or hospitalization of patients on chronic hemodialysis is associated with a physician-based diagnosis of depression. Kidney Int. 2008;74(7):930-6.
25. Sifneos PE. The prevalence of 'alexithymic' characteristics in psychosomatic patients. Psychother Psychosom. 1973;22(2): 255-62.
26. Taylor GJ, Bagby RM. New trends in alexithymia research. Psychother Psychosom. 2004;73(2):68-77.
27. Kauhanen J, Kaplan GA, Cohen RD, Julkunen J, Salonen JT. Alexithymia and risk of death in middle-aged men. J Psychosom Res. 1996;41(6):541-9.
28. Bagby RM, Parker JD, Taylor GJ. The twenty-item Toronto Alexithymia Scale-I. Item selection and cross-validation of the factor structure. J Psychosom Res. 1994;38(1):23-32.
29. Bagby RM, Taylor GJ, Parker JD. The Twenty-item Toronto Alexithymia Scale-II. Convergent, discriminant, and concurrent validity. J Psychosom Res. 1994;38(1):33-40.